Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

SELL
$1.02 - $2.57 $1,058 - $2,667
-1,038 Reduced 1.92%
53,018 $56,000
Q3 2023

Nov 13, 2023

BUY
$2.52 - $5.69 $3,633 - $8,204
1,442 Added 2.74%
54,056 $138,000
Q2 2023

Aug 11, 2023

BUY
$5.0 - $7.66 $4,015 - $6,150
803 Added 1.55%
52,614 $285,000
Q3 2022

Nov 14, 2022

BUY
$2.13 - $4.0 $1,071 - $2,012
503 Added 0.98%
51,811 $118,000
Q2 2022

Aug 11, 2022

SELL
$1.88 - $3.42 $46,796 - $85,130
-24,892 Reduced 32.67%
51,308 $151,000
Q1 2022

May 13, 2022

BUY
$2.06 - $3.0 $156,972 - $228,600
76,200 New
76,200 $219,000

Others Institutions Holding ASRT

About Assertio Holdings, Inc.


  • Ticker ASRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 48,178,200
  • Market Cap $40.5M
  • Description
  • Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...
More about ASRT
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.